Feed CGC
CG

Canopy Growth Corporation

CGC · NASDAQ

$0.94 +0.90% (+$0.01)
1M -6.16%
Market Cap $550.7M
P/E Ratio -
Div. Yield -
ROE 32.79%

Bulios Fair Price

$0.6

36.1% downside

Trenutna cena

$0.94

Podcenjeno Poštena vrednost Precenjeno

Po podatkih Bulios Fair Price je delnica CGC trenutno precenjena glede na svojo tržno ceno. Kako deluje?

Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?

Piotroski F-Score Moderate
4/9
Valuation
92 /100
Cheap
P/B 0.80x
P/S 1.71x
EV/FFO N/A
Growth
65 /100
Stable
Book val. growth 2.75%
Rev. growth 13.22%
FCF growth N/A
Profitability
9 /100
Weak
Net margin 80.67%
Op. margin 31.94%
FCF margin 26.04%
Quality
4 /100
Poor
ROE 32.79%
ROA 23.49%
Asset turnover 0.29x
Debt
65 /100
Moderate
Current ratio 3.04x
Int. coverage -5.21x
Debt/Equity 0.40x
Stability
22 /100
Unstable
Rev. volatility 51.94%
EPS volatility 28.19%
Profitable years 0

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o CGC
Online

O podjetju

Canopy Growth Corporation (CGC) is one of the leading global producers and retailers of legal medical cannabis and related products. The company operates in various areas of the cannabis industry, including cultivation, processing, research, and the development of new products. Canopy Growth has its own brands offering a wide range of cannabinoid-containing products, including CBD and THC. The company also has strategic partnerships with pharmaceutical companies and invests in innovative cannabis-related projects. With its global reach and expansion into new markets, Canopy Growth holds a solid position in the cannabis market. Investing in Canopy Growth Corporation (CGC) shares can be an interesting choice for investors who follow the medical cannabis sector and seek a company with potential for growth in the growing industry.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Luc Mongeau

Employees

1,128

Headquarters

Smiths Falls

Prihajajoči dogodki

06 NOV.

Earnings

Upcoming earnings report

52d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.